515 POSTER Zoledronic Acid (ZOL) treatment may improve survival in patients with lung cancer and high baseline N-telopeptide levels: a multivariate Cox regression analysis
Conferences
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- September 2007
has subject area
- Oncology & Carcinogenesis (Science Metrix)
published in
presented at event
- 14th European Cancer Conference (ECCO 14) Conference